StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN)
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note released on Thursday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.6 % NASDAQ:LPCN opened at $0.29 on Thursday. The firm has a fifty day simple moving average of $0.40 and a […]